The type 2 cytokine Fc–IL-4 revitalizes exhausted CD8+ T cells against cancer
Bing Feng(Chinese Academy of Sciences), Li Tang(École Polytechnique Fédérale de Lausanne), Zhiliang Bai(Yale University), Yuqing Xie(École Polytechnique Fédérale de Lausanne), Werner Held(Centre National de la Recherche Scientifique), Mei-Wen Peng(École Polytechnique Fédérale de Lausanne), Yi Wang(École Polytechnique Fédérale de Lausanne), J. Joseph Melenhorst(Cleveland Clinic), Yugang Guo(University of Science and Technology of China), Lucia Bonati(École Polytechnique Fédérale de Lausanne), Mélanie Charmoy(University of Lausanne), Xiaolei Zhou(Karolinska Institutet), Yang Liu(Mudanjiang Medical University), Rongrong Li(Qilu Hospital of Shandong University), Yang Zhao(École Polytechnique Fédérale de Lausanne), Min Gao(Central South University), Weilin Li(South China Normal University), Bo Tao(Yale University), Xinyi Huang(École Polytechnique Fédérale de Lausanne), Tom Enbar(École Polytechnique Fédérale de Lausanne), Rong Fan(Yale Cancer Center)
Cited by 118
Related Papers
T Cell Factor 1-Expressing Memory-like CD8+ T Cells Sustain the Immune Response to Chronic Viral Infections
|Immunity|2016|1.1k
The technological landscape and applications of single-cell multi-omics
|Nature Reviews Molecular Cell Biology|2023|916
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
|Nature Biotechnology|2018|641
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
|Nature Immunology|2021|422